Alector Q4 net loss $37.3M ($0.34/share); revenue down 89% YoY; cash $256M

Alector, Inc.

2025-FY EPS reported -$1.39 revenue$21,045,000

Q4 2025 net loss $37.3M vs $2.1M in Q4 2024; full-year net loss $142.9M ($1.39/share).
Collaboration revenue fell to $6.2M in Q4 from $54.2M a year earlier; full-year revenue $21M.
Cash, equivalents and investments $256M; company expects runway at least through 2027.
Independent interim futility analysis for PROGRESS-AD Phase 2 trial of nivisnebart expected H1 2026.
ABC-led pipeline advancing: AL137 IND filing planned Q4 2026/Q1 2027; AL050 IND target 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.